Hates what Hasbro does to MTG, to D&D, to the toy division..It's a bad company in general with great IP

---

MTG previously was a product with a huge moat - it was self-moating. It had been continually worldbuilding since it's inception. Now that it's just a vehicle to sell shit based on other IP, there's literally nothing special about it. Hasbro destroyed the moat on their own property. We've seen Palworld basically ripping off Pokemon and mostly getting away with it, Hasbro has made MTG vulnerable to some other company creating an alternative TCG that steals the rich rule system of MTG but fixes all the 'problems' it has. It could be a new TCG based on an established fantasy or sci-fi IP, or it could be an entirely newly written lore, in either case Hasbro will be absolutely fucked if/when this happens. Once MTG has a serious competitor, resale value will plummet and people will cease buying new sealed product to speculate on valuable pulls.

---

Funny enough, Archer also got sued by Wisk (Boeing) for stealing IP, and the settlement involved Archer issuing a ton of warrants to Boeing plus letting them be the sole autonomous tech provider. Archer’s legally prohibited from even pursuing their own autonomous flight tech stack. It’s a dog shit company with no legitimate future.

---

Don't blatantly copy protected IP and you won't get sued

---

This is not about the right/approval to manufacture, but the right/approval to market and sell to citizens. Making it in Canada solves none of the issues. FDA approval still needed, patent/IP protections still apply, etc.

---

Someone wake Google ip

---

725M of their revenue last year was GLP-1 sales. That's about a third of their total revenue they posted last year. They're a growing company with profitable base, but the GLP-1 headwinds from these looming lawsuits will continue to drive the price down in the short term. They are also abusing an FDA loophole to allow 'personalized' compounded variants of Wegovy to continue to be sold to a small subset of their customer base. This is what Novo is trying to put a stop to. Before that, they were straight up able to market a knock-off due to the drug being on shortage due to another FDA loophole. However when Semaglutide shortage ended in Q1 last year, they continued to sell the personalized version. Their audacity to sell the Wegovy pill without any licensing agreement was incredibly risky, but given a third of the company's 2025 revenue was attributed to stealing and undercutting Novo's IP, I can understand why they took that chance. I made a lot of money off HIMs in 2025, I am not in it now and probably won't buy it after this.

---

It open season on A list likenesses....lol....IP attorneys licking their chops....

---

They don't have the funds to develop a new IP unless it is essentially an assassin's creed reskin

---

Yeah, it seems like a good time to buy. Sure, they might go bankrupt, but I doubt it. More than likely, the stock bounces around for a while until they announce a new IP or two.

---